Cargando…
Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease
[Image: see text] Modulation of multiple biological targets with a single drug can lead to synergistic therapeutic effects and has been demonstrated to be essential for efficient treatment of CNS disorders. However, rational design of compounds that interact with several targets is very challenging....
Autores principales: | Jaiteh, Mariama, Zeifman, Alexey, Saarinen, Marcus, Svenningsson, Per, Bréa, Jose, Loza, Maria Isabel, Carlsson, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716773/ https://www.ncbi.nlm.nih.gov/pubmed/29792714 http://dx.doi.org/10.1021/acs.jmedchem.8b00204 |
Ejemplares similares
-
Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology
por: Kampen, Stefanie, et al.
Publicado: (2021) -
Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity
por: Jaiteh, Mariama, et al.
Publicado: (2020) -
GM1 Is Cytoprotective in GPR37-Expressing Cells and Downregulates Signaling
por: Hertz, Ellen, et al.
Publicado: (2021) -
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP-363856
por: Saarinen, Marcus, et al.
Publicado: (2022) -
Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP- 363856
por: Saarinen, Marcus, et al.
Publicado: (2022)